Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion type Assertion NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_head.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion description "[When the severity of gastric atrophy was classified into the following three groups: non-atrophy (NA) (atrophy score=0 and metaplasia score=0); severe atrophy (SA) (atrophy score?2 or metaplasia score?2) and mild atrophy (MA) (all others), both the GSTT1 and GSTM1 null genotypes held significantly higher risk for developing more severe gastric atrophy (GSTT1 null, SA vs. others: OR=1.95, 95% CI=1.07-3.52, p=0.028, GSTM1 null, NA vs. others: OR=2.57, 95% CI=1.16-5.67, p=0.019, SA vs. others: OR=1.90, 95% CI=1.06-3.42, p=0.032).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_provenance.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion evidence source_evidence_literature NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_provenance.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion SIO_000772 21508403 NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_provenance.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion wasDerivedFrom befree-20140225 NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_provenance.
- NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_assertion wasGeneratedBy ECO_0000203 NP446458.RAmxu2JYfZzZV5Mtbx66VuZTx62RrXs0YxZky8shEiVAM130_provenance.